IT202200009101A1 - Composizione antiossidante per prevenire e trattare stati infiammatori delle vie respiratorie in particolare dei polmoni - Google Patents
Composizione antiossidante per prevenire e trattare stati infiammatori delle vie respiratorie in particolare dei polmoni Download PDFInfo
- Publication number
- IT202200009101A1 IT202200009101A1 IT102022000009101A IT202200009101A IT202200009101A1 IT 202200009101 A1 IT202200009101 A1 IT 202200009101A1 IT 102022000009101 A IT102022000009101 A IT 102022000009101A IT 202200009101 A IT202200009101 A IT 202200009101A IT 202200009101 A1 IT202200009101 A1 IT 202200009101A1
- Authority
- IT
- Italy
- Prior art keywords
- lung
- prevent
- antioxidant composition
- treat inflammatory
- respiratory tracts
- Prior art date
Links
- 239000003963 antioxidant agent Substances 0.000 title 1
- 230000003078 antioxidant effect Effects 0.000 title 1
- 230000002757 inflammatory effect Effects 0.000 title 1
- 210000004072 lung Anatomy 0.000 title 1
- 210000002345 respiratory system Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102022000009101A IT202200009101A1 (it) | 2022-05-04 | 2022-05-04 | Composizione antiossidante per prevenire e trattare stati infiammatori delle vie respiratorie in particolare dei polmoni |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102022000009101A IT202200009101A1 (it) | 2022-05-04 | 2022-05-04 | Composizione antiossidante per prevenire e trattare stati infiammatori delle vie respiratorie in particolare dei polmoni |
Publications (1)
Publication Number | Publication Date |
---|---|
IT202200009101A1 true IT202200009101A1 (it) | 2023-11-04 |
Family
ID=83188803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102022000009101A IT202200009101A1 (it) | 2022-05-04 | 2022-05-04 | Composizione antiossidante per prevenire e trattare stati infiammatori delle vie respiratorie in particolare dei polmoni |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT202200009101A1 (it) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013067284A1 (en) * | 2011-11-04 | 2013-05-10 | The Leland Stanford Junior University | Methods of improving or preserving lung function in a patient with a pulmonary disorder |
US20130273175A1 (en) * | 2012-04-15 | 2013-10-17 | Jahahreeh Finley | Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation |
WO2016210226A1 (en) * | 2015-06-26 | 2016-12-29 | Stc.Unm | Coenzyme q10 aerosol |
WO2018017434A1 (en) * | 2016-07-16 | 2018-01-25 | Burch Lauranell Harrison | Methods for treating cystic fibrosis and other diseases affecting mucosal surfaces |
WO2020081886A1 (en) * | 2018-10-18 | 2020-04-23 | The Regents Of The University Of California | Homotaurine for treatment of inflammation-related disorders |
WO2021216749A1 (en) * | 2020-04-22 | 2021-10-28 | George Edward Hoag | Method for treating viral and bacterial infection through inhalation therapy |
US20210369741A1 (en) * | 2020-05-27 | 2021-12-02 | Northwestern University | Vitamin d as an immune modulator to prevent immune-related complication from covid-19 infection |
WO2022011305A2 (en) * | 2020-07-09 | 2022-01-13 | Beyond Barriers Therapeutics, Inc. | Intranasal administration of an antioxidant compound for treating coronavirus infection |
-
2022
- 2022-05-04 IT IT102022000009101A patent/IT202200009101A1/it unknown
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013067284A1 (en) * | 2011-11-04 | 2013-05-10 | The Leland Stanford Junior University | Methods of improving or preserving lung function in a patient with a pulmonary disorder |
US20130273175A1 (en) * | 2012-04-15 | 2013-10-17 | Jahahreeh Finley | Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation |
WO2016210226A1 (en) * | 2015-06-26 | 2016-12-29 | Stc.Unm | Coenzyme q10 aerosol |
WO2018017434A1 (en) * | 2016-07-16 | 2018-01-25 | Burch Lauranell Harrison | Methods for treating cystic fibrosis and other diseases affecting mucosal surfaces |
WO2020081886A1 (en) * | 2018-10-18 | 2020-04-23 | The Regents Of The University Of California | Homotaurine for treatment of inflammation-related disorders |
WO2021216749A1 (en) * | 2020-04-22 | 2021-10-28 | George Edward Hoag | Method for treating viral and bacterial infection through inhalation therapy |
US20210369741A1 (en) * | 2020-05-27 | 2021-12-02 | Northwestern University | Vitamin d as an immune modulator to prevent immune-related complication from covid-19 infection |
WO2022011305A2 (en) * | 2020-07-09 | 2022-01-13 | Beyond Barriers Therapeutics, Inc. | Intranasal administration of an antioxidant compound for treating coronavirus infection |
Non-Patent Citations (9)
Title |
---|
ABDULLAH CETIN TANRIKULU ET AL: "Coenzyme Q10, Copper, Zinc, and Lipid Peroxidation Levels in Serum of Patients with Chronic Obstructive Pulmonary Disease", BIOLOGICAL TRACE ELEMENT RESEARCH, HUMANA PRESS INC, NEW YORK, vol. 143, no. 2, 16 November 2010 (2010-11-16), pages 659 - 667, XP019961015, ISSN: 1559-0720, DOI: 10.1007/S12011-010-8897-5 * |
CAZZOLA MARIO ET AL: "Use of Thiols in the Treatment of COVID-19: Current Evidence", LUNG, SPRINGER NEW YORK LLC, US, vol. 199, no. 4, 1 August 2021 (2021-08-01), pages 335 - 343, XP037555045, ISSN: 0341-2040, [retrieved on 20210827], DOI: 10.1007/S00408-021-00465-3 * |
GUPTA R C ET AL: "TAURINE ANALOGUES; A NEW CLASS OF THERAPEUTICS: RETROSPECT AND PROSPECTS", CURRENT MEDICINAL CHEMISTRY, BENTHAM, NL, vol. 12, no. 17, 1 January 2005 (2005-01-01), pages 2021 - 2039, XP009082995, ISSN: 0929-8673, DOI: 10.2174/0929867054546582 * |
I. RAHMAN ET AL: "Oxidative stress and regulation of glutathione in lung inflammation", EUROPEAN RESPIRATORY JOURNAL, vol. 16, no. 3, 1 September 2000 (2000-09-01), pages 534 - 554, XP055036719, ISSN: 0903-1936, DOI: 10.1034/j.1399-3003.2000.016003534.x * |
SAHEBNASAGH ADELEH ET AL: "The prophylaxis and treatment potential of supplements for COVID-19", EUROPEAN JOURNAL OF PHARMACOLOGY, ELSEVIER SCIENCE, NL, vol. 887, 1 September 2020 (2020-09-01), XP086323297, ISSN: 0014-2999, [retrieved on 20200901], DOI: 10.1016/J.EJPHAR.2020.173530 * |
SIFUENTES-FRANCO SONIA ET AL: "Antioxidant and Anti-Inflammatory Effects of Coenzyme Q10 Supplementation on Infectious Diseases", HEALTHCARE, vol. 10, no. 3, 1 January 2022 (2022-01-01), pages 487, XP093009132, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953254/pdf/healthcare-10-00487.pdf> DOI: 10.3390/healthcare10030487 * |
TALLARIDA RJ.: "Drug Synergism:its detection and applications.", J PHARMACOL EXPTHER, vol. 298, no. 3, September 2001 (2001-09-01), pages 865 - 72, XP007918154 |
TIAN JIDE ET AL: "GABAA-Receptor Agonists Limit Pneumonitis and Death in Murine Coronavirus-Infected Mice", VIRUSES, vol. 13, no. 6, 23 May 2021 (2021-05-23), pages 966, XP093009129, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224554/pdf/viruses-13-00966.pdf> DOI: 10.3390/v13060966 * |
ZHANG QIANWEN ET AL: "N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia : A randomized controlled trial", MEDICINE, vol. 97, no. 45, 1 November 2018 (2018-11-01), US, pages e13087, XP093009131, ISSN: 0025-7974, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250560/pdf/medi-97-e13087.pdf> DOI: 10.1097/MD.0000000000013087 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2008009725A (es) | Formulaciones de glucocorticosteroide de materia en nanoparticulas esterilizadas. | |
PE20081788A1 (es) | Combinaciones farmaceuticas | |
MX2019003397A (es) | Metodos para tratar trastornos mitocondriales y metabolicos. | |
HRP20121034T1 (hr) | Lijeäśenje upalnih bolesti | |
BR112014005358A2 (pt) | composição para alívio da dor, compreendendo um agonista seletivo de trpv1, e a sua fabricação e utilização | |
PE20141532A1 (es) | Nuevos sulfoxidos de piperidino-dihidrotienopirimidina y su uso para tratar epoc y asma | |
HK1137807A1 (en) | Diagnosis of infections or inflammatory diseases of the airways and lungs associated with heart failure | |
BR112012012476A2 (pt) | "composições nutritivas incluindo um componente de alta proteína e nucleotídeos exôgenos" | |
WO2011141685A3 (fr) | Compositions nasales a visee systemique a base de cocoyl proline ou d'au moins un de ses constituants | |
BR112016006064A2 (pt) | composição de pró-dentifrício, composição com base em glicerina, e, kit para terapia da mucosa oral | |
AR125850A2 (es) | Composición farmacéutica tópica, proceso de producción de la composición farmacéutica tópica, uso de la composición farmacéutica tópica y método de tratamiento tópico de psoriasis, dermatitis atópica o eczemas crónicos | |
EP4272839A3 (en) | Treatment of allergic rhinitis using a combination of mometasone and olopatadine | |
EA201990529A1 (ru) | Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний | |
BR112014030534A2 (pt) | composições de galacto-ramnogalacturonato para o tratamento de doenças associadas com óxido nítrico sintase induzível elevada | |
MX2015017457A (es) | Uso de una composicion que comprende aceite de pescado y jugo para el tratamiento de inflamacion. | |
SMT201700098B (it) | Aclidinio per l'uso nel miglioramento della qualità del sonno in pazienti con malattie respiratorie | |
MX2019004402A (es) | Metodos para el tratamiento de las condiciones relacionadas con la inflamacion utilizando moduladores antiinflamatorios y metabolicos pluripotentes. | |
GB201215873D0 (en) | Compositions and methods relating to the treatment of allergy and allergic diseases | |
BR112015001859A2 (pt) | tratamento de inflamação utilizando serelaxina | |
IT202200009101A1 (it) | Composizione antiossidante per prevenire e trattare stati infiammatori delle vie respiratorie in particolare dei polmoni | |
IL272253A (en) | Preparations and methods for treating inflammatory conditions of the skin | |
BR112015014262A2 (pt) | formulação farmacêutica, dispositivo adaptado para distribuição intranasal de uma formulação farmacêutica, método de tratamento de rinite alérgica, uso de uma formulação farmacêutica, e, método para o tratamento de condição inflamatória e/ou alérgica | |
BR112013018688A2 (pt) | processo para a produção de composição polimérica de proantocianidina | |
BR112014004737A2 (pt) | composto de composição de cloridrato de ambroxol e método de preparação do composto | |
IL297304A (en) | The composition for treating respiratory symptoms, and methods of using it |